BAYER USING AI TO IMPROVE DISEASE DIAGNOSIS, DRUG DESIGN
Oct 05, 2019
2 minutes
Image: Benoit Tessier
Drugmakers have embraced artificial intelligence — using computers to analyze reams of data and then make predictions or recommendations.
Germany’s Bayer has been testing how the technology can help diagnose complex or rare conditions, hasten drug development and more.
The aspirin-creator has partnered with
You’re reading a preview, subscribe to read more.
Start your free 30 days